Scientific article
English

UHPLC-MS-based HDAC Assay Applied to Bio-guided Microfractionation of Fungal Extracts

Published inPhytochemical analysis, vol. 28, no. 2, p. 93-100
Publication date2017
Abstract

Histone deacetylases (HDAC) are considered as promising targets for cancer treatment. Today, four HDAC inhibitors, vorinostat, romidepsin, belinostat, and panobinostat, have been approved by the Food and Drug Administration (FDA) for cancer treatment, while others are in clinical trials. Among them, several are naturally occurring fungal metabolites.

Keywords
  • Chromatography
  • High Pressure Liquid/methods
  • Fungi/metabolism
  • Histone Deacetylases/metabolism
  • Tandem Mass Spectrometry/methods
Citation (ISO format)
ZWICK, Vincent et al. UHPLC-MS-based HDAC Assay Applied to Bio-guided Microfractionation of Fungal Extracts. In: Phytochemical analysis, 2017, vol. 28, n° 2, p. 93–100. doi: 10.1002/pca.2652
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN0958-0344
472views
3downloads

Technical informations

Creation14/06/2017 01:04:00
First validation14/06/2017 01:04:00
Update time15/03/2023 02:47:28
Status update15/03/2023 02:47:27
Last indexation31/10/2024 08:12:42
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack